Cerebral malaria is one of the major complications of Plasmodium falciparum infection. Plasmodium malaria infection is endemic in this part of the world. The study was done to evaluate the changes in haematological profile of cerebral malaria (CM) patients attending a secondary hospital in Enugu State, Southeast, Nigeria. A total of 70 subjects were recruited for the study, 20 were cerebral malaria subjects aged 1-5 years and 50 were control subjects aged matched. The haematological profile was determined using Mindray BC-5300. The results showed significant difference (P<0.05) in WBC, RBC, Hb, MCV, MCH, MCHC and Platelets of the cerebral malaria subjects compared to the control and no significant difference (P>0.05) in absolute neutrophil, absolute lymphocyte, absolute monocyte, absolute eosinophil, and absolute basophil. The effect of cerebral malaria was seen in the red cell line and WBC. This could lead to anaemia and increased chances of low immunity to infections. The red cell line of cerebral malaria patients should be monitored to avoid anemia with its increased chances of high mortality and morbidity. The patients should be properly feed.
A cross-sectional assessment of some inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and interleukin-10 (IL-10) concentrations and parasitaemia levels in 162 pregnant women and 160 children infected with Plasmodium falciparum parasites in Port Harcourt, Nigeria, were evaluated. Blood samples collected from the subjects were analyzed, and the blood plasma analysed for cytokine using commercial standard enzyme linked immunosorbent assay kit. Malaria diagnosis and some blood parameters were carried out using standard parasitological and haematological techniques. Pregnant women with falciparum malaria within age group 29-33 years had the highest infection rate of 41%, and mean parasitaemia level of 7955.11±1225.75 parasites/μl while those within the age group 19-23 years had the least mean parasitaemia level of 5042.00±900.18 parasites/μl, and the difference was not statistically significant (P=0.328). Comparatively, children within the age group 3-5 had the highest prevalence of 53.8%, those within 9-11 years had the highest mean parasitaemia level of 4813.03±1180.05 parasites/μl while those within age 6-8 years had lowest mean parasitaemia level of 2324.62±546.63 parasites/μl. The mean difference was statistically significant (P=0.048). The mean concentration levels of cytokines IL-6, and IL-10 (176.32±27.34 pg/ml, and 329.09±19.11 pg/ml, and 376.78±24.95pg/ml respectively) were significantly elevated in pregnant women with severe parasitaemia compared with their concentration levels in mild and moderate parasitaemia; The mean concentration levels of IL-6, and IL-10 (81.79±6.36pg/ml, 24.67±2.00pg/ml, 365.30±40.31 pg/ml, and 318.57±39.29 pg/ml respectively) were significantly higher in children with severe parasitaemia (P=0.6857, 0.1816, P=0.0014, and 0.0347 respectively).The mean cytokine levels of TNF-α, IL-β, IL-6, and IL-10, were significantly elevated in pregnant women and children with P. falciparum infection when compared to their respective healthy matched controls (P<0.0001). Correlations between plasma levels of IL-6 and P. falciparum parasite density in the study population showed a relatively strong positive linear relationship (P<0.0001). Inflammatory cytokines are involved in immunopathogenesis and immunoregulation of Plasmodium falciparum infection. Cytokines as found in this study could be used as promising prognostic and diagnostic biomarkers for falciparum malaria progression or regression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.